NEW YORK (Reuters Health) – Researchers from Spain have found a strong and independent link between cannabis use and early age at onset of psychosis. The association, they…
NEW YORK (Reuters Health) – Vascular-targeted photodynamic therapy (VTP) using the light-activated drug Tookad offers promise as an effective, minimally invasive salvage therapy for men with recurrent prostate…
NEW YORK (Reuters Health) – New research suggests that the neonatal intensive care unit (NICU) is a good setting for administering the tetanus, diphtheria, and acellular pertussis vaccine…
NEW YORK (Reuters Health) – In a postmortem study of patients with Alzheimer’s disease, diabetic subjects treated with both insulin and oral hypoglycemic agents had lower neuritic plaque…
NEW YORK (Reuters Health) – The results of a new study suggest that patients receiving long-term warfarin therapy do not need to stop the drug prior to coronary…
NEW YORK (Reuters Health) – Men who gain weight during adulthood – even those who are not considered to be overweight according to their body mass index –…
NEW YORK (Reuters Health) – Increased sperm DNA fragmentation is observed in infertile men with genitourinary infection by Chlamydia trachomatis and Mycoplasma, according to a report in the…
NEW YORK (Reuters Health) – In patients with severe chronic obstructive pulmonary disease (COPD), lung volume reduction surgery (LVRS) improves arterial blood oxygenation and decreases the need for…
NEW YORK (Reuters Health) – The calcium metabolism defects that are prevalent in children with untreated celiac disease resolve after a gluten-free diet has begun, the results of…
NEW YORK (Reuters Health) – The diagnosis of colorectal cancer will be delayed or missed in a substantial number of patients with inflammatory bowel disease (IBD) if colonoscopic…
John D. Kelly, IV, MD, Vice Chairman/Director, Sports Medicine/Orthopaedics, Temple University School of Medicine, discusses simple treatments to reduce the painful symptoms associated with arthritis. References and Resources…
NEW YORK (Reuters Health) – Dasatinib, a second-generation dual-specific BCR-ABL kinase inhibitor penetrates the blood-brain barrier and has promising therapeutic potential for Philadelphia chromosome-positive leukemia that has spread…
